Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.
In the latest trading session, Cathie Wood's ARK ETFs continued to adjust their portfolios, with significant moves seen in both buying and selling across various sectors. The largest transaction for ...
EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...
Qualcomm generated earnings of $3.41 a share in the latest quarter, versus Wall Street’s estimate for $2.96.
James reiterated its Outperform rating and Cdn$34.00 price target for Torex Gold Resources (TXG:CN) (OTC: OTC:TORXF). The firm's analyst highlighted the company's significant progress on its Media ...
Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
After reaching all-time nominal highs amid sustained haven demand, gold prices plateaued in 4Q24, ending the quarter with a ...
February 05, 2025, 03:25 AM ET, BY Thomas H. Kee Jr, Editor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...
ARK Invest's 13F portfolio value increased by ~10% to ~$12B this quarter. Check out the top holdings and new stakes of the ...
Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over ...
Construction substantially complete and first copper concentrate on track for March (All amounts expressed in U.S. dollars ...
RBC Dominion Securities analyst James McGarragle saw Monday’s 4-per-cent drop in shares of Exchange Income Corp. (EIF-T) as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results